The settlement resolves allegations that Aperian paid kickbacks to marketing companies in exchange for arranging for physicians across the nation to refer toxicology tests to the lab, according to The Times-News. EAMC and Aperian allegedly submitted claims for the toxicology lab tests to Medicare in violation of the False Claims Act.
A former Aperian employee brought the case under the qui tam, or whistle-blower, provisions of the False Claims Act.
The $4.25 million settlement is in addition to earlier settlements in the same case that totaled nearly $2.4 million, according to The Times-News.
More articles on legal and regulatory issues:
11 latest healthcare industry lawsuits
Partners, Massachusetts Eye and Ear settle deceptive billing allegations
Physician pleads guilty in $60M fraud scheme allegedly linked to patient deaths
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
